首页> 外文期刊>BMC Musculoskeletal Disorders >Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database
【24h】

Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database

机译:新临床预测模型建立和验证软骨肉瘤肺转移的风险分析:基于SEER数据库的临床研究

获取原文
           

摘要

The prognosis of lung metastasis (LM) in patients with chondrosarcoma was poor. The aim of this study was to construct a prognostic nomogram to predict the risk of LM, which was imperative and helpful for clinical diagnosis and treatment. Data of all chondrosarcoma patients diagnosed between 2010 and 2016 was queried from the Surveillance, Epidemiology, and End Results (SEER) database. In this retrospective study, a total of 944 patients were enrolled and randomly splitting into training sets (n?=?644) and validation cohorts(n?=?280) at a ratio of 7:3. Univariate and multivariable logistic regression analyses were performed to identify the prognostic nomogram. The predictive ability of the nomogram model was assessed by calibration plots and receiver operating characteristics (ROCs) curve, while decision curve analysis (DCA) and clinical impact curve (CIC) were applied to measure predictive accuracy and clinical practice. Moreover, the nomogram was validated by the internal cohort. Five independent risk factors including age, sex, marital, tumor size, and lymph node involvement were identified by univariate and multivariable logistic regression. Calibration plots indicated great discrimination power of nomogram, while DCA and CIC presented that the nomogram had great clinical utility. In addition, receiver operating characteristics (ROCs) curve provided a predictive ability in the training sets (AUC?=?0.789, 95% confidence interval [CI] 0.789–0.808) and the validation cohorts (AUC?=?0.796, 95% confidence interval [CI] 0.744–0.841). In our study, the nomogram accurately predicted risk factors of LM in patients with chondrosarcoma, which may guide surgeons and oncologists to optimize individual treatment and make a better clinical decisions. JOSR-D-20-02045, 29 Dec 2020.
机译:软骨肉瘤患者肺转移(LM)的预后差。本研究的目的是构建预后的载体,以预测LM的风险,这是临床诊断和治疗的迫切和乐于助人。从监测,流行病学和最终结果(SEER)数据库中查询诊断的所有软骨糖瘤患者的数据。在这项回顾性研究中,共注册了944名患者,并以7:3的比例为训练集(n?=Δ444)和验证队列(n?=Δ280)。进行单变量和多变量的逻辑回归分析以鉴定预后的NOM图。通过校准图和接收器操作特性(ROCS)曲线评估NOM图模型的预测能力,而判决曲线分析(DCA)和临床冲击曲线(CIC)被应用于测量预测准确性和临床实践。此外,ROMAROM由内部队列验证。通过单变量和多变量的逻辑回归鉴定包括年龄,性别,婚姻,肿瘤大小和淋巴结受累的五个独立风险因素。校准绘图表明了NOM图的差异很大,而DCA和CIC呈现说明图具有良好的临床效用。此外,接收器操作特性(ROCS)曲线在训练集中提供了预测能力(AUC?= 0.789,95%置信区间[CI] 0.789-0.808)和验证队列(AUC?=?0.796,95%的信心间隔[CI] 0.744-0.841)。在我们的研究中,NOM图准确地预测了软骨肉瘤患者LM的危险因素,这可能导致外科医生和肿瘤学家优化个体治疗并进行更好的临床决策。 JOSR-D-20-02045,20 Dec 2020。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号